No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Chimerix: On June 27, Got Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard From Nasdaq
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
Buy Rating Justified by Chimerix's Upcoming Catalysts and Strong Financials
Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript
Strong Buy Rating for Chimerix on Robust Financials and Promising Drug Pipeline
No Data